Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05272319 · ClinicalTrials.gov registry record
Genetic Collection Protocol
A clinical trial of Liver Diseases, sponsored by Arbor Research Collaborative for Health.
- Recruiting
- Registry status
- 2,230
- Enrollment target
- 13
- Study locations
NCT05272319: Recruiting study of Liver Diseases, sponsored by Arbor Research Collaborative for Health.
NCT05272319 is a study of Liver Diseases that is actively recruiting participants, run by Arbor Research Collaborative for Health. The registered enrollment target is 2,230 participants, below the 61,091-participant average among 33 other Liver Diseases trials with a reported enrollment target (96% lower). The trial reports 13 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05272319, a study of Liver Diseases, is actively recruiting participants, sponsored by Arbor Research Collaborative for Health.
- RECRUITING
- Registry status
- 2,230 participants
- Enrollment target
- 13
- Study locations
Study Summary
This study involves the one-time collection of whole blood or saliva samples for the extraction and storage of DNA for use in ongoing and future ChiLDReN studies.
Primary Outcome
The major objective of this protocol is to augment a repository of DNA from participants previously enrolled into clinical research but for whom a DNA biosample was not previously collected. The acquisition and storage of DNA from participants will make available an important resource for future and ongoing studies that may evaluate etiology, pathogenesis, biomarkers, pharmacogenomics, and genetic modifiers of these rare disorders.
Conditions Studied
Study Locations (13)
California
- Children's Hospital of Los Angeles - Los Angeles
- UCSF Benioff Children's Hospital - San Francisco
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
- UPMC Children's Hospital of Pittsburgh - Pittsburgh
Colorado
- Children's Hospital Colorado - Aurora
Georgia
- Children's Healthcare of Atlanta - Atlanta
Illinois
- Lurie Children's Hospital - Chicago
Indiana
- Riley Hospital for Children - Indianapolis
Ohio
- Cincinnati Children's Hospital - Cincinnati
Texas
- Texas Children's Hospital; Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,230 participants |
| Start Date | 2022-04-06 |
| Est. Completion | 2029-05-31 |
What NCT05272319 shows while recruiting
NCT05272319 is an observational study that tracks outcomes without assigning an intervention. Its 2,230 participants enrollment target places it among the larger protocols in the corpus, below the 61,091-participant average among 33 other Liver Diseases trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Liver Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT05272319 lists 13 locations in 11 states (California, Pennsylvania, Colorado).
Frequently Asked Questions
What is clinical trial NCT05272319 about?
NCT05272319 is a clinical study titled "Genetic Collection Protocol". This study involves the one-time collection of whole blood or saliva samples for the extraction and storage of DNA for use in ongoing and future ChiLDReN studies.
What is the current status of trial NCT05272319?
This trial is currently recruiting. The enrollment target is 2,230 participants. The study started on 2022-04-06. Estimated completion is 2029-05-31.
What conditions does trial NCT05272319 study?
This clinical trial studies the following conditions: Liver Diseases.
Who is sponsoring clinical trial NCT05272319?
This trial is sponsored by Arbor Research Collaborative for Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05272319 being conducted?
This trial has 13 study locations across California, Colorado, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05272319's enrollment target sits among peer trials
2,230 4th of 33 higher than 30 of 33 other Liver Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
RECRUITING · NA
-
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
RECRUITING · NA
-
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
RECRUITING
-
The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial
RECRUITING · Phase 1
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI